Molecular Templates to Present at the Upcoming Investor Conferences

Rhea-AI Summary

Molecular Templates, Inc. (Nasdaq: MTEM), a clinical-stage biopharmaceutical company, will participate in several upcoming investor conferences. The key events include Cowen’s 42nd Annual Health Care Conference on March 8, 2022, Oppenheimer’s 32nd Annual Healthcare Conference on March 16, 2022, and Barclays Global Healthcare Conference 2022 on March 15, 2022. Each conference will feature a corporate presentation, showcasing the company’s innovative engineered toxin bodies (ETBs) for cancer treatments. Webcast links will be available on their corporate website.

AUSTIN, Texas, March 01, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of the company’s proprietary engineered toxin bodies (ETBs), which are differentiated, targeted, biologic therapeutics for cancer and other serious diseases, will participate in several upcoming investor conferences.

Details can be found below:
Cowen’s 42nd Annual Health Care Conference (March 7-9, 2022)
Format:	Corporate Presentation
Date:	Tuesday, March 8th
Time:	10:30 AM – 11:00 AM ET
Oppenheimer’s 32nd Annual Healthcare Conference (March 15-16, 2022)
Format:	Corporate Presentation
Date:	Wednesday, March 16
Time:	2:00 PM – 2:30 PM ET
Barclays Global Healthcare Conference 2022 (March 15-17, 2022)
Format:	Corporate Presentation
Date:	Tuesday, March 15
Time:	4:20 PM - 4:45 PM ET

Webcast links for the presentations will be posted on the “News and Media” section of the Molecular Templates corporate website, under Events.

About Molecular Templates  
Molecular Templates is a clinical-stage company focused on the discovery and development of targeted biologic therapeutics. Our proprietary drug platform technology, known as engineered toxin bodies, or ETBs, leverages the resident biology of a genetically engineered form of Shiga-like Toxin A subunit to create novel therapies with potent and differentiated mechanisms of action for cancer and other serious diseases.

Investor Contact:
Joyce Allaire
LifeSci Advisors, LLC
jallaire@lifesciadvisors.com

Source: Molecular Templates, Inc.

FAQ

What is the significance of Molecular Templates' participation in the upcoming investor conferences?

Molecular Templates' participation signifies its commitment to engaging with investors and showcasing its innovative therapies at major healthcare conferences.

When is the Cowen’s 42nd Annual Health Care Conference taking place for MTEM?

The Cowen’s 42nd Annual Health Care Conference for MTEM is scheduled for March 8, 2022.

What time will Molecular Templates present at the Oppenheimer’s 32nd Annual Healthcare Conference?

Molecular Templates will present on March 16, 2022, from 2:00 PM to 2:30 PM ET.

Where can I find the webcast links for Molecular Templates' presentations?

Webcast links for the presentations will be available in the 'News and Media' section of the Molecular Templates corporate website.

What is the focus of Molecular Templates' drug technology?

Molecular Templates focuses on engineered toxin bodies (ETBs) designed for targeted biologic therapeutics to treat cancer and serious diseases.